Quarterly Result27 May 2026, 05:01 pm
Hikal Ltd FY26: Revenue ₹1,713 Cr, PAT ₹14 Cr
AI Summary
Hikal Ltd announced its audited financial results for the quarter and year ended March 31, 2026. The company reported revenue of ₹519 crore for Q4FY26 and ₹1,713 crore for the full year FY26. EBITDA stood at ₹105 crore for the quarter, with margins of 20.3%. The Board has approved a final dividend of 20% of FV, bringing the total dividend for the year to 30%. The company's long-term credit rating is A (Stable) by ICRA. The Pharmaceutical business showed sequential improvement, while the Crop Protection business accelerated during the quarter. Hikal is focusing on diversification into Personal Care and Specialty Chemicals.
Key Highlights
- Hikal's Q4FY26 revenue reached ₹519 Cr with EBITDA margin at 20.3%.
- FY26 revenue stood at ₹1,713 Cr with an EBITDA margin of 12.9%.
- Board approved a final dividend of 20%, totaling 30% for the year.
- Pharmaceutical business saw improved demand and CDMO pipeline growth.
- Crop Protection revenues grew 45% QoQ and 13% YoY in Q4FY26.
Price Impact
More from HIKAL